{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:18Z","timestamp":1767135138302,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011742.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000}}],"reference-count":108,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011742.pub3","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:28:35Z","timestamp":1576729715000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cell-based therapies for amyotrophic lateral sclerosis\/motor neuron disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"S Fadilah","family":"Abdul Wahid","sequence":"first","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe Kang","family":"Law","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Department of Medicine, Faculty of Medicine; Kuala Lumpur Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nor Azimah","family":"Ismail","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai Ming","family":"Lai","sequence":"additional","affiliation":[{"name":"Taylor's University; School of Medicine; Subang Jaya Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/j.jcyt.2017.02.297","article-title":"In vivo modulation of neurotrophic and inflammatory factors in the CSF of ALS patients treated with NurOwn (MSC NTF cells).","volume":"19","author":"Aricha","year":"2017","journal-title":"Cytotherapy"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD011742.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S25.005","DOI":"10.1212\/WNL.90.15_supplement.S25.005","article-title":"Modulation of CSF mirnas in ALS phase 2 study participants treated with MSC-NTF cells (NurOwn)","volume":"90","author":"Aricha","year":"2018","journal-title":"Neurology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcyt.2017.02.040","article-title":"Safety and efficacy of transplantation of NurOwn (autologous mesenchymal stromal cells secreting neurotrophic factors) in patients with ALS: a phase 2 randomized double blind placebo controlled trial","volume":"19","author":"Gothelf","year":"2017","journal-title":"Cryotherapy"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD011742.pub3-BIB0004|cit4","first-page":"Abstract No:S38","article-title":"NurOwn phase 2 ALS trial: ALSFRS-R improvement is reflected in subscale domains","volume":"90","author":"Kern","year":"2018","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0005|cit5","unstructured":"NCT02017912 A phase 2, randomised, double blind, placebo controlled multicenter study to evaluate safety and efficacy of transplantation of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in patients with ALS clinicaltrials.gov\/ct2\/show\/study\/NCT02017912"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0007|cit6","first-page":"S228","article-title":"Phase I\/II trials of autologous BM derived stem cell therapy in ALS","volume":"56","author":"Kim","year":"2016","journal-title":"Clinical Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0006|cit7","first-page":"53","article-title":"A phase 2 study for safety and efficacy evaluation of treatment of amyotrophic lateral sclerosis using autologous bone-marrow-derived stromal cell","volume":"16","author":"Kim","year":"2015","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0008|cit8","unstructured":"NCT01363401 Safety and efficacy study of autologous bone marrow derived stem cell treatment in amyotrophic lateral sclerosis clinicaltrials.gov\/ct2\/show\/NCT01363401"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.25302","article-title":"Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"84","author":"Oh","year":"2018","journal-title":"Annals of Neurology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.jcyt.2017.02.299","article-title":"Intrathecal autologous bone marrow derived mesenchymal stem cell therapy for amyotrophic lateral sclerosis","volume":"19","author":"Gabr","year":"2017","journal-title":"Cytotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1007\/s00415-013-6924-0","article-title":"Treatment of amyotrophic lateral sclerosis (ALS) with autologous differentiated mesenchymal stem cells: preliminary results of a phase I\/II clinical trial in 12 patients","volume":"260","author":"Karussis","year":"2013","journal-title":"Journal of Neurology"},{"issue":"19","key":"10.1002\/14651858.CD011742.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1212\/WNL.0b013e3182924c84","article-title":"Interim analysis of 12 patients with amyotrophic lateral sclerosis (ALS) treated with autologous differentiated mesenchymal stem cells: preliminary data of a Phase I\/II clinical trial","volume":"80","author":"Karussis","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","article-title":"Human neural stem cell transplantation in ALS: initial results from a phase I trial","volume":"13","author":"Mazzini","year":"2015","journal-title":"Journal of Translational Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0015|cit15","first-page":"243","article-title":"Data from a completed phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis","volume":"17","author":"Mazzini","year":"2016","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0016|cit16","first-page":"592","article-title":"Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase I clinical trial","volume":"20","author":"Nabavi","year":"2019","journal-title":"Cell Journal"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD011742.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jcyt.2015.03.434","article-title":"Update on clinical trials with autologous bone marrow-derived mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in patients with amyotrophic lateral sclerosis (ALS)","volume":"17","author":"Gothelf","year":"2015","journal-title":"Cytotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011742.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/21678421.2013.838413\/078","article-title":"Analysis of patients with amyotrophic lateral sclerosis (ALS) treated with autologous differentiated mesenchymal stem cells: a phase I\/II and IIA clinical trial","volume":"14","author":"Karussis","year":"2013","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/s00415-013-6924-0","article-title":"Analysis of patients with amyotrophic lateral sclerosis (ALS) treated with autologous differentiated mesenchymal stem cells: A phase I\/II and IIa clinical trial","volume":"261","author":"Karussis","year":"2014","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurology"},{"issue":"14 Suppl","key":"10.1002\/14651858.CD011742.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"P2.059","DOI":"10.1212\/WNL.84.14_supplement.P2.059","article-title":"Autologous transplantation of mesenchymal stem cells secreting neurotrophic factors (NurownTM) in ALS: results of a phase 2 clinical trial","volume":"84","author":"Petrou","year":"2015","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011742.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/S1388-2457(14)50634-7","article-title":"Cellular therapy in amyotrophic lateral sclerosis. Preliminary results of a phase I\/II clinical trial","volume":"125","author":"Henriquez","year":"2014","journal-title":"Clinical Neurophysiology"},{"issue":"12","key":"10.1002\/14651858.CD011742.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"A49","DOI":"10.1089\/hum.2013.2513","article-title":"Bone marrow mononuclear cell therapy for amyotrophic lateral sclerosis. Preliminary results of a randomised, double-blind, stratified controlled, parallel group phase I-II clinical trial","volume":"24","author":"Iniesta","year":"2013","journal-title":"Human Gene Therapy"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0024|cit24","unstructured":"NCT01254539 Phase I\/II clinical trial on the use of autologous bone marrow stem cells in amyotrophic lateral sclerosis (Extension CMN\/ELA) clinicaltrials.gov\/ct2\/show\/NCT01254539 (accessed September 2015)"},{"issue":"Supp s1","key":"10.1002\/14651858.CD011742.pub3-BIB0025|cit25","first-page":"40: Abstract no","article-title":"Phase I\/II clinical trial of intramuscular implantation of autologous bone marrow stem cells in amyotrophic lateral sclerosis patients","volume":"111","author":"Cano","year":"2012","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0026|cit26","unstructured":"EUCTR2011-004801-25-ES A phase I\/II clinical trial of the bone marrow's autologous stem cells in patients with amyotrophic lateral sclerosis www.clinicaltrialsregister.eu\/ctr-search\/trial\/2011-004801-25\/ES (accessed September 2015)"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0027|cit27","unstructured":"NCT02286011 Intramuscular infusion of autologous bone marrow stem cells in patients with amyotrophic lateral sclerosis (TCIM\/ELA) clinicaltrials.gov\/ct2\/show\/NCT02286011"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0028|cit28","unstructured":"NCT02290886 A multicenter phase I\/II clinical trial to evaluate safety of mesenchymal stem cell in patients with amyotrophic sclerosis lateral clinicaltrials.gov\/ct2\/show\/study\/NCT02290886"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0029|cit29","unstructured":"NCT03280056 Safety and efficacy of repeated administrations of NurOwn\u00ae in ALS patients clinicaltrials.gov\/ct2\/show\/study\/NCT03280056"},{"issue":"8","key":"10.1002\/14651858.CD011742.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010747.pub2","article-title":"Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients","author":"Abdul Wahid","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7-8","key":"10.1002\/14651858.CD011742.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0032|cit32","first-page":"261","article-title":"Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis","volume":"56","author":"Baek","year":"2012","journal-title":"Journal of Neurosurgical Sciences"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD011742.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","article-title":"Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms","volume":"67","author":"Bernardo","year":"2007","journal-title":"Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1006\/bcmd.2001.0423","article-title":"Adult rat and human bone marrow stromal stem cells differentiate into neurons","volume":"27","author":"Black","year":"2001","journal-title":"Blood Cells, Molecules & Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011742.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/stem.1080","article-title":"Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study","volume":"30","author":"Blanquer","year":"2012","journal-title":"Stem Cells"},{"issue":"2","key":"10.1002\/14651858.CD011742.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z","article-title":"Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size","volume":"20","author":"Campbell","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0733-8619(18)30931-9","article-title":"Amyotrophic lateral sclerosis. Its natural history","volume":"5","author":"Caroscio","year":"1987","journal-title":"Neurologic Clinics"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mus.20951","article-title":"Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS)","volume":"37","author":"Cashman","year":"2008","journal-title":"Muscle & Nerve"},{"issue":"1-2","key":"10.1002\/14651858.CD011742.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/17482960903093710","article-title":"Clinical significance in the change of decline in ALSFRS-R","volume":"11","author":"Castrillo-Viguera","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"1-2","key":"10.1002\/14651858.CD011742.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/jnnp.60.4.455","article-title":"Motor neuron disease presenting as acute respiratory failure: a clinical and pathological study","volume":"60","author":"Chen","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0045|cit45","first-page":"961","article-title":"Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis","volume":"21","author":"Chen","year":"2007","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke za Zhi [Chinese Journal of Reparative and Reconstructive Surgery]"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.biocel.2008.01.007","article-title":"Mesenchymal stem cells: a promising candidate in regenerative medicine","volume":"40","author":"Chen","year":"2008","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/17482960701419315","article-title":"Olfactory ensheathing glia injections in Beijing: misleading patients with ALS","volume":"8","author":"Chew","year":"2007","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"2","key":"10.1002\/14651858.CD011742.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/14653240903300682","article-title":"Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study","volume":"43","author":"Chio","year":"2011","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0049|cit49","first-page":"25","article-title":"Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis","volume":"43","author":"Cruz","year":"2018","journal-title":"P & T : a Peer-reviewed Journal for Formulary Management"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/14653240802549470","article-title":"Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up","volume":"11","author":"Deda","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0051|cit51","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/01.WNL.0000049472.47709.3B","article-title":"Prognosis in amyotrophic lateral sclerosis: a population-based study","volume":"60","author":"Aguila","year":"2003","journal-title":"Neurology"},{"issue":"7363","key":"10.1002\/14651858.CD011742.pub3-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.clinph.2016.06.011","article-title":"MUNIX: reproducibility and clinical correlations in amyotrophic lateral sclerosis","volume":"127","author":"Escorcio-Bezerra","year":"2016","journal-title":"Clinical Neurophysiology"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jelekin.2015.11.001","article-title":"Motor unit number estimation as a complementary test to routine electromyography in the diagnosis of amyotrophic lateral sclerosis","volume":"26","author":"Gawel","year":"2016","journal-title":"Journal of Electromyography and Kinesiology"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1750-3639.2009.00353.x","article-title":"Neuropathology of olfactory ensheathing cell transplantation into the brain of two amyotrophic lateral sclerosis (ALS) patients","volume":"20","author":"Giordana","year":"2010","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"11","key":"10.1002\/14651858.CD011742.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010854","article-title":"Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment","volume":"8","author":"Goodall","year":"2006","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011742.pub3-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s13311-015-0339-9","article-title":"Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis","volume":"12","author":"Goutman","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","article-title":"Stem cell transplantation for motor neuron disease: current approaches and future perspectives","volume":"8","author":"Gowing","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0061|cit61","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2018"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-010-8136-2","article-title":"Human embryonic stem cell-derived neurons as a tool for studying neuroprotection and neurodegeneration","volume":"42","author":"Hardingham","year":"2010","journal-title":"Molecular Neurobiology"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0063|cit63","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0064|cit64","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD011742.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1399-0012.2008.00865.x","article-title":"Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study","volume":"22","author":"Huang","year":"2008","journal-title":"Clinical Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD011742.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(00)00420-2","article-title":"The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients","volume":"180","author":"Jenkinson","year":"2000","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0269215506071123","article-title":"Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey","volume":"21","author":"Jenkinson","year":"2007","journal-title":"Clinical Rehabilitation"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD011742.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.jcyt.2015.03.530","article-title":"Systematic review and meta-analysis of efficacy and safety of stem cell therapy in amyotrophic lateral sclerosis","volume":"17","author":"Jeong","year":"2015","journal-title":"Cytotherapy"},{"issue":"6893","key":"10.1002\/14651858.CD011742.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1002\/14651858.CD011742.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00001756-200207020-00023","article-title":"Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro","volume":"13","author":"Kim","year":"2002","journal-title":"Neuroreport"},{"issue":"11","key":"10.1002\/14651858.CD011742.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1073\/pnas.97.11.6126","article-title":"Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation","volume":"97","author":"Liu","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1002\/14651858.CD011742.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.2004.039180","article-title":"Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study","volume":"76","author":"Logroscino","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","article-title":"Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues","volume":"79","author":"Logroscino","year":"2008","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.1628","article-title":"Concise review: stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future","volume":"32","author":"Lunn","year":"2014","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/14653240802644651","article-title":"Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients","volume":"11","author":"Martinez","year":"2009","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3727\/096368911X582769","article-title":"Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility","volume":"21","author":"Martinez","year":"2012","journal-title":"Cell Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/14660820310014653","article-title":"Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans","volume":"4","author":"Mazzini","year":"2003","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1179\/016164106X116791","article-title":"Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis","volume":"28","author":"Mazzini","year":"2006","journal-title":"Neurological Research"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/14653249.2011.613929","article-title":"Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study","volume":"14","author":"Mazzini","year":"2012","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1002\/14651858.CD011742.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/70986","article-title":"Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord","volume":"5","author":"McDonald","year":"1999","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011742.pub3-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"317","DOI":"10.14740\/jocmr2495w","article-title":"Efficacy of stem cell therapy in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"8","author":"Moura","year":"2016","journal-title":"Journal of Clinical Medicine Research"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0085|cit85","first-page":"2223","article-title":"Disorders of upper and lower motor neurons","volume-title":"Neurology in Clinical Practice","volume":"1","author":"Murray","year":"2004"},{"issue":"1-2","key":"10.1002\/14651858.CD011742.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/17482960902933809","article-title":"Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study","volume":"11","author":"Nefussy","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","article-title":"TBK1: a new player in ALS linking autophagy and neuroinflammation","volume":"10","author":"Oakes","year":"2017","journal-title":"Molecular Brain"},{"issue":"6","key":"10.1002\/14651858.CD011742.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5966\/sctm.2014-0212","article-title":"Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis","volume":"4","author":"Oh","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/17482961003663555","article-title":"No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS","volume":"11","author":"Piepers","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/0028-3886.103185","article-title":"Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study","volume":"60","author":"Prabhakar","year":"2012","journal-title":"Neurology India"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-4612-1602-5_20","article-title":"Motor neuron disease","volume-title":"Cell Death and Diseases of the Nervous System","author":"Rabin","year":"1999"},{"issue":"5","key":"10.1002\/14651858.CD011742.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Annals of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004427.pub3","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","author":"Radunovic","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0095|cit95","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011742.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7389","article-title":"Adult bone marrow stromal cells differentiate into neural cells in vitro","volume":"164","author":"Sanchez-Ramos","year":"2000","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011742.pub3-BIB0097|cit97","first-page":"50","article-title":"The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in amyotrophic lateral sclerosis - a retrospective controlled study","volume":"4","author":"Sharma","year":"2015","journal-title":"American Journal of Stem Cells"},{"issue":"8","key":"10.1002\/14651858.CD011742.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp.2004.048652","article-title":"Molecular and cellular pathways of neurodegeneration in motor neurone disease","volume":"76","author":"Shaw","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD011742.pub3-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jelekin.2016.02.001","article-title":"Toward the validation of a new method (MUNIX) for motor unit number assessment","volume":"27","author":"Stein","year":"2016","journal-title":"Journal of Electromyography and Kinesiology"},{"issue":"6880","key":"10.1002\/14651858.CD011742.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature730","article-title":"Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion","volume":"416","author":"Terada","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1002\/14651858.CD011742.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/157488809789057392","article-title":"Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis","volume":"4","author":"Thonhoff","year":"2009","journal-title":"Current Stem Cell Research & Therapy"},{"issue":"7","key":"10.1002\/14651858.CD011742.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jnnp.74.7.995","article-title":"Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002","volume":"74","author":"Turner","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD011742.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1002\/14651858.CD011742.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"4","key":"10.1002\/14651858.CD011742.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C","article-title":"Adult rat and human bone marrow stromal cells differentiate into neurons","volume":"61","author":"Woodbury","year":"2000","journal-title":"Journal of Neuroscience Research"},{"issue":"7","key":"10.1002\/14651858.CD011742.pub3-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing Group","year":"2017","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011742.pub3-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011742","article-title":"Cell-based therapies for amyotrophic lateral sclerosis\/motor neuron disease","author":"Abdul Wahid","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011742.pub3-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011742.pub2","article-title":"Cell-based therapies for amyotrophic lateral sclerosis\/motor neuron disease","author":"Abdul Wahid","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011742.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T18:13:59Z","timestamp":1722190439000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011742.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":108,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011742.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]}}}